Klatt O, de Brouwer L, Hendriks F, Dehne E, Atac Wagegg B, Jennings P
    
    
    Arch Toxicol. 2025; .
  
  
    PMID: 40032686
    
    
          DOI: 10.1007/s00204-025-03987-4.
      
 
                                  
  
    Wang Y, Qin J
    
    
    Life Med. 2025; 2(1):lnad007.
  
  
    PMID: 39872958
    
          PMC: 11749282.
    
          DOI: 10.1093/lifemedi/lnad007.
      
 
                                  
  
    Zhou D, Li D, Nie H, Duan J, Liu S, Wang Y
    
    
    Life Med. 2025; 2(6):lnad047.
  
  
    PMID: 39872058
    
          PMC: 11749593.
    
          DOI: 10.1093/lifemedi/lnad047.
      
 
                                  
  
    Du H, Guo L, Lian J, Qiu H, Mao Y, Yi F
    
    
    Life Med. 2025; 3(3):lnae022.
  
  
    PMID: 39871891
    
          PMC: 11749467.
    
          DOI: 10.1093/lifemedi/lnae022.
      
 
                                  
  
    Liu J, Zhang Y, Yu Y
    
    
    Cell Mol Life Sci. 2025; 82(1):33.
  
  
    PMID: 39751829
    
          PMC: 11699091.
    
          DOI: 10.1007/s00018-024-05557-w.
      
 
                              
              
                              
                                      
  Wilms tumor primary cultures capture phenotypic heterogeneity and facilitate preclinical screening.
  
    Gotz L, Wegert J, Paikari A, Appenzeller S, Bausenwein S, Vokuhl C
    
    
    Transl Oncol. 2024; 52():102263.
  
  
    PMID: 39740515
    
          PMC: 11750297.
    
          DOI: 10.1016/j.tranon.2024.102263.
      
 
                                          
                                                          
  Metabolic profiling of patient-derived organoids reveals nucleotide synthesis as a metabolic vulnerability in malignant rhabdoid tumors.
  
    Kes M, Morales-Rodriguez F, Zaal E, de Souza T, Proost N, van de Ven M
    
    
    Cell Rep Med. 2024; 6(1):101878.
  
  
    PMID: 39708810
    
          PMC: 11866552.
    
          DOI: 10.1016/j.xcrm.2024.101878.
      
 
                                          
                                                          
  Embracing sex-specific differences in engineered kidney models for enhanced biological understanding of kidney function.
  
    Veser C, Carlier A, Dubois V, Mihaila S, Swapnasrita S
    
    
    Biol Sex Differ. 2024; 15(1):99.
  
  
    PMID: 39623463
    
          PMC: 11613810.
    
          DOI: 10.1186/s13293-024-00662-8.
      
 
                                          
                                                          
  Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy.
  
    Taurin S, Alzahrani R, AlOraibi S, Ashi L, Alharmi R, Hassani N
    
    
    Transl Oncol. 2024; 51:102226.
  
  
    PMID: 39622151
    
          PMC: 11647637.
    
          DOI: 10.1016/j.tranon.2024.102226.
      
 
                                          
                                                          
  Trends and challenges in organoid modeling and expansion with pluripotent stem cells and somatic tissue.
  
    Ge J, Wang Y, Li Q, Liu F, Lei Q, Zheng Y
    
    
    PeerJ. 2024; 12:e18422.
  
  
    PMID: 39619184
    
          PMC: 11608026.
    
          DOI: 10.7717/peerj.18422.
      
 
                                          
                                                          
  Cell Catcher: A New Method to Extract and Preserve Live Renal Cells from Urine.
  
    Nazmutdinova K, Man C, Carter M, Beales P, Winyard P, Walsh S
    
    
    Kidney360. 2024; 5(9):1359-1363.
  
  
    PMID: 39591363
    
          PMC: 11441801.
    
          DOI: 10.34067/KID.0000000000000503.
      
 
                                          
                                                          
  Recent advances in extracellular matrix manipulation for kidney organoid research.
  
    Wang R, Sui Y, Liu Q, Xiong Y, Li S, Guo W
    
    
    Front Pharmacol. 2024; 15:1472361.
  
  
    PMID: 39568581
    
          PMC: 11576200.
    
          DOI: 10.3389/fphar.2024.1472361.
      
 
                                          
                                                          
  Liver organoids: updates on generation strategies and biomedical applications.
  
    Liu S, Cheng C, Zhu L, Zhao T, Wang Z, Yi X
    
    
    Stem Cell Res Ther. 2024; 15(1):244.
  
  
    PMID: 39113154
    
          PMC: 11304926.
    
          DOI: 10.1186/s13287-024-03865-3.
      
 
                                          
                                                          
  Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models.
  
    Wang E, Xiang K, Zhang Y, Wang X
    
    
    J Natl Cancer Cent. 2024; 2(4):263-276.
  
  
    PMID: 39036550
    
          PMC: 11256726.
    
          DOI: 10.1016/j.jncc.2022.10.001.
      
 
                                          
                                                          
  A Decade of Organoid Research: Progress and Challenges in the Field of Organoid Technology.
  
    Ahammed B, Kalangi S
    
    
    ACS Omega. 2024; 9(28):30087-30096.
  
  
    PMID: 39035960
    
          PMC: 11256333.
    
          DOI: 10.1021/acsomega.4c03683.
      
 
                                          
                                                          
  Progress and breakthroughs in human kidney organoid research.
  
    Liu Q, Yue L, Deng J, Tan Y, Wu C
    
    
    Biochem Biophys Rep. 2024; 39:101736.
  
  
    PMID: 38910872
    
          PMC: 11190488.
    
          DOI: 10.1016/j.bbrep.2024.101736.
      
 
                                          
                                                          
  Organoids as a new approach for improving pediatric cancer research.
  
    Lampis S, Galardi A, Di Paolo V, Di Giannatale A
    
    
    Front Oncol. 2024; 14:1414311.
  
  
    PMID: 38835365
    
          PMC: 11148379.
    
          DOI: 10.3389/fonc.2024.1414311.
      
 
                                          
                                                          
  A multispectral 3D live organoid imaging platform to screen probes for fluorescence guided surgery.
  
    Jeremiasse B, van Ineveld R, Bok V, Kleinnijenhuis M, de Blank S, Alieva M
    
    
    EMBO Mol Med. 2024; 16(7):1495-1514.
  
  
    PMID: 38831131
    
          PMC: 11251264.
    
          DOI: 10.1038/s44321-024-00084-4.
      
 
                                          
                                                          
  Enhancing maturity in 3D kidney micro-tissues through clonogenic cell combinations and endothelial integration.
  
    Abdollahzadeh F, Khoshdel-Rad N, Bahrehbar K, Erfanian S, Ezzatizadeh V, Totonchi M
    
    
    J Cell Mol Med. 2024; 28(11):e18453.
  
  
    PMID: 38818569
    
          PMC: 11140233.
    
          DOI: 10.1111/jcmm.18453.
      
 
                                          
                                                          
  A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine.
  
    Kalla J, Pfneissl J, Mair T, Tran L, Egger G
    
    
    Cell Oncol (Dordr). 2024; 48(1):1-26.
  
  
    PMID: 38806997
    
          PMC: 11850459.
    
          DOI: 10.1007/s13402-024-00960-8.